Correlation of clinical response with homocysteine reduction during therapy with reduced B vitamins in patients with MDD who are positive for MTHFR C677T or A1298C polymorphism / Arnold W. Mech en The Journal of Clinical Psychiatry, Año 2016 - Vol.77 - No.5 (Mayo)

Público ISBD [artículo]  inThe Journal of Clinical Psychiatry > Año 2016 - Vol.77 - No.5 (Mayo) . - pp. 668–671 Título : Correlation of clinical response with homocysteine reduction during therapy with reduced B vitamins in patients with MDD who are positive for MTHFR C677T or A1298C polymorphism : A randomized, double-blind, placebo-controlled studa Tipo de documento: texto impreso Autores: Arnold W. Mech, Autor ; Andrew Farah, Autor Fecha de publicación: 2020 Artículo en la página: pp. 668–671 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno depresivo mayor, Homocisteína, Metilenetetrahidrofolato reductasa (NADPH2), Micronutrientes, Complejo de vitamina B. Resumen: This study was designed to evaluate the efficacy and safety of reduced B vitamins as monotherapy in adults with major depressive disorder (MDD) who were also positive for at least 1 methylenetetrahydrofolate reductase (MTHFR) polymorphism associated with depression and further test the hypothesis that reduced (metabolized) B vitamins will lower homocysteine in a majority of clinically responding patients. Link: ./index.php?lvl=notice_display&id=21741 [artículo] Correlation of clinical response with homocysteine reduction during therapy with reduced B vitamins in patients with MDD who are positive for MTHFR C677T or A1298C polymorphism : A randomized, double-blind, placebo-controlled studa [texto impreso] / Arnold W. Mech, Autor ; Andrew Farah, Autor . - 2020 . - pp. 668–671. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The Journal of Clinical Psychiatry > Año 2016 - Vol.77 - No.5 (Mayo) . - pp. 668–671 Palabras clave: Trastorno depresivo mayor, Homocisteína, Metilenetetrahidrofolato reductasa (NADPH2), Micronutrientes, Complejo de vitamina B. Resumen: This study was designed to evaluate the efficacy and safety of reduced B vitamins as monotherapy in adults with major depressive disorder (MDD) who were also positive for at least 1 methylenetetrahydrofolate reductase (MTHFR) polymorphism associated with depression and further test the hypothesis that reduced (metabolized) B vitamins will lower homocysteine in a majority of clinically responding patients. Link: ./index.php?lvl=notice_display&id=21741

---

1 (1 - 1 / 1)